Approval · Notice of Compliance 38156 · 2026
DOXYTAB: Notice of Compliance 38156
Issued August 21, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38156
- Date
- August 21, 2026
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Update to labelling (to match licensor)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOXYTAB | Not yet assigned | — |
Medicinal ingredients
- DOXYCYCLINE HYCLATE 100 MG per TAB